The Multiple Sclerosis Care Unit
暂无分享,去创建一个
Gavin Giovannoni | Xavier Montalban | Giancarlo Comi | Paola Zaratin | X. Montalban | G. Comi | G. Giovannoni | P. Soelberg Sørensen | Per Soelberg Sorensen | Christoph Thalheim | P. Zaratin | C. Thalheim
[1] Patrick Vermersch,et al. The patient's perspective: How to create awareness for improving access to care and treatment of MS patients? , 2016, Multiple sclerosis.
[2] V. Martinelli,et al. Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres , 2017, European journal of neurology.
[3] O. Ciccarelli,et al. All relapsing multiple sclerosis patients should be managed at a specialist clinic – YES , 2016, Multiple sclerosis.
[4] D. Mohr,et al. Effects of Treatment for Depression on Fatigue in Multiple Sclerosis , 2003, Psychosomatic medicine.
[5] Pierre Grammond,et al. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response , 2017, Brain : a journal of neurology.
[6] D. Mazevet,et al. Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: A prospective, randomized, controlled study , 2015, Multiple sclerosis journal - experimental, translational and clinical.
[7] C. Walsh,et al. Impact of stroke units on mortality: a Bayesian analysis , 2010, European journal of neurology.
[8] L. von Koch,et al. Use of health care services and satisfaction with care in people with multiple sclerosis in Stockholm County: A population-based study , 2008, Multiple sclerosis.
[9] G. Comi,et al. Evolving concepts in the treatment of relapsing multiple sclerosis , 2017, The Lancet.
[10] A. Langer-Gould. The pill times 2 , 2014, Neurology.
[11] O. Kantarci,et al. Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – YES , 2016, Multiple sclerosis.
[12] H. Mitsumoto,et al. Subcommittee of the American Academy of Neurology Evidence-based Review) : Report of the Quality Standards Management, and Cognitive/behavioral Impairment (an Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Practice Parameter Update: the Care of the Patient With , 2022 .
[13] P. Sørensen. Safety concerns and risk management of multiple sclerosis therapies. , 2017 .
[14] G. Fenu,et al. What do multiple sclerosis patients and their caregivers perceive as unmet needs? , 2013, BMC Neurology.
[15] J. Pionke,et al. Barriers to the Accessibility and Continuity of Health-Care Services in People with Multiple Sclerosis: A Literature Review. , 2017, International journal of MS care.
[16] G. Comi,et al. Survey of diagnostic and treatment practices for multiple sclerosis in Europe , 2017, European journal of neurology.
[17] O. Hardiman,et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000 , 2003, Journal of neurology, neurosurgery, and psychiatry.
[18] P. Clavelou. Can we optimize our teams? Multidisciplinary care for multiple sclerosis , 2013, Expert review of neurotherapeutics.
[19] Margaret Anderson,et al. On the path to a science of patient input , 2016, Science Translational Medicine.
[20] Xavier Montalban,et al. Treatment decisions in multiple sclerosis — insights from real-world observational studies , 2017, Nature Reviews Neurology.
[21] Gavin Giovannoni,et al. The importance of a multi-disciplinary perspective and patient activation programmes in MS management , 2016, Multiple sclerosis.
[22] A. Thompson,et al. Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper , 2016, Multiple sclerosis.
[23] L. Widén Holmqvist,et al. Variations in functioning and disability in multiple sclerosis , 2008, Journal of Neurology.
[24] C. Lubetzki,et al. Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – NO , 2016, Multiple Sclerosis.
[25] A. Lo,et al. Treatment of progressive multiple sclerosis: what works, what does not, and what is needed , 2015, The Lancet Neurology.
[26] O. Ciccarelli,et al. Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions , 2010, The Lancet Neurology.
[27] Jeffrey A. Cohen,et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review , 2015, Multiple sclerosis.
[28] Peter Langhorne,et al. Organised inpatient (stroke unit) care for stroke. , 2007, The Cochrane database of systematic reviews.
[29] O. Hardiman,et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[30] M. Pollack,et al. Comprehensive Stroke Units: A Review of Comparative Evidence and Experience , 2013, International journal of stroke : official journal of the International Stroke Society.
[31] A. Thompson,et al. Exercise in patients with multiple sclerosis , 2017, The Lancet Neurology.
[32] P. Soelberg Sørensen. Safety concerns and risk management of multiple sclerosis therapies , 2017, Acta neurologica Scandinavica.
[33] M. Hutchinson,et al. Unmet needs of multiple sclerosis patients in the community. , 2015, Multiple sclerosis and related disorders.